Canada markets open in 1 hour 37 minutes

Arbutus Biopharma Corporation (ABUS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.2100+0.1400 (+4.56%)
At close: 04:00PM EDT
3.1983 -0.01 (-0.36%)
After hours: 07:59PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
12,986
18,141
39,019
10,988
6,914
-
Cost of Revenue
-
-
-
-
47,481
57,601
Gross Profit
-
-
-
-
-40,567
-51,590
Operating Expenses
Research Development
70,828
73,700
84,408
65,502
49,338
-
Selling General and Administrative
22,235
22,475
17,834
17,136
14,845
-
Total Operating Expenses
93,063
96,175
102,242
82,638
64,183
-
Operating Income or Loss
-80,077
-78,034
-63,223
-71,650
-57,269
-
Interest Expense
305
459
1,726
2,857
4,011
-
Total Other Income/Expenses Net
32
-44
-2,255
-1,867
-3,206
-
Income Before Tax
-74,385
-72,849
-65,012
-76,247
-63,745
-
Income Tax Expense
-
0
4,444
0
0
-
Income from Continuing Operations
-74,385
-72,849
-69,456
-76,247
-63,745
-
Net Income
-74,385
-72,849
-69,456
-76,247
-63,745
-
Net Income available to common shareholders
-74,385
-72,849
-69,456
-88,386
-75,868
-
Basic EPS
-0.46
-
-0.46
-0.83
-1.00
-2.89
Diluted EPS
-0.46
-
-0.46
-0.83
-1.00
-2.89
Basic Average Shares
162,714
-
150,939
106,242
75,835
57,093
Diluted Average Shares
162,714
-
150,939
106,242
75,835
57,093